SMCI Short โ€” Gap-Down Breakdown, Dead-Cat Bounce Into Supply

85
๐Ÿ“‰ SHORT SMCI @ $21.49 ๐ŸŽฏ Target $19.50 ๐Ÿ›‘ Stop $22.50

โš–๏ธ R:R 1.97:1 | ๐Ÿง  Confidence 72% | โฑ๏ธ Swing (1-2 weeks)

---
๐Ÿ”‘ The Setup

SMCI gapped down -30% on March 20 โ€” from $30.80 to $22 โ€” on 55 million shares ๐Ÿคฏ (vs 3M avg). That's not retail panic, that's institutional distribution ๐Ÿฆ๐Ÿ’จ

The bounce from $19.48 to $21.50 is a textbook dead-cat rally ๐Ÿฑ back into the gap supply zone. Every dollar of this recovery is lower-volume, lower-conviction selling opportunity.

๐Ÿ“Š Why Short Here

๐Ÿ—๏ธ Structure:
- ๐Ÿ“‰ Multi-month downtrend from $50+ (Oct) to $20s โ€” no sustained base anywhere
- ๐Ÿ’ฅ Gap-down on 15x average volume confirms structural breakdown
- ๐Ÿงฑ $22-23 = prior breakdown candle body, now overhead resistance
- ๐Ÿ˜ด Bounce stalling with fading volume โ€” sellers reloading at the level

๐Ÿ”ฎ Options Flow:
- ๐Ÿป Net bearish sentiment: -$470K
- ๐Ÿ“Œ Heavy put buying at $20 and $21 strikes across near-term expiries
- ๐Ÿ’ฐ Bearish premium $1.19M vs bullish $724K
- ๐ŸŒก๏ธ IV at 90%+ โ€” market pricing continued downside

๐Ÿ—บ๏ธ Key Levels

๐Ÿงฑ Resistance: $22.00-22.50 (gap supply zone, breakdown candle body)
๐Ÿ‘‰ Entry: $21.49 (dead-cat bounce into resistance)
๐Ÿ›‘ Stop: $22.50 (above gap supply โ€” thesis invalidated)
๐ŸŽฏ Target: $19.50 (prior intraday low, room to extend)
๐Ÿ›Ÿ Support: $19.48 (Mar 23 flush low)

๐Ÿ’ก The Trade

Fading the bounce at resistance in a confirmed downtrend โฌ‡๏ธ The massive gap-down volume created a wall of overhead supply ๐Ÿงฑ that should cap any recovery attempts. If $22.50 holds as
resistance, gravity takes over ๐Ÿช‚

๐Ÿ›‘ Invalidation: Close above $22.50 โ€” that would mean the gap is being reclaimed and the breakdown thesis is wrong โŒ

๐ŸŽฏ Target logic: $19.50 is the prior intraday low. If momentum continues, $18 and $16 are the next structural supports from the longer-term chart ๐Ÿ“

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.